Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuo-Sheng Hsu

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Vitamins and Hormones|July 2, 2013
Alpha-actinin 4 and tumorigenesis of breast cancerKuo-Sheng Hsu, Hung-Ying Kao
Cell & Bioscience|February 9, 2018
PML: Regulation and multifaceted function beyond tumor suppressionKuo-Sheng Hsu, Hung-Ying Kao
Cell & Bioscience|March 13, 2018
Correction to: PML: Regulation and multifaceted function beyond tumor suppressionKuo-Sheng Hsu, Hung-Ying Kao
The Journal of Biological Chemistry|July 18, 2013
β-Transducin repeat-containing protein 1 (β-TrCP1)-mediated silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) protein degradation promotes tumor necrosis factor α (TNFα)-induced inflammatory gene expressionKuo-Sheng Hsu, Hung-Ying Kao
The Journal of Biological Chemistry|November 21, 2014
α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding functionXuan Zhao, Kuo-Sheng Hsu, Jun Hee Lim, et al.
The Journal of Biological Chemistry|April 23, 2017
Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon α-mediated inhibition of angiogenesisKuo-Sheng Hsu, Xuan Zhao, Xiwen Cheng, et al.
Science Advances|February 14, 2024
Uncovering receptor-ligand interactions using a high-avidity CRISPR activation screening platformLiping Yang, Timothy P Sheets, Yang Feng, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Engineering Functionality Optimized fully human B7-H3 CAR T Cells for Enhanced Solid Tumor TherapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
Cell Reports. Medicine|April 30, 2026
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Vitamins and Hormones|July 2, 2013
Alpha-actinin 4 and tumorigenesis of breast cancerKuo-Sheng Hsu, Hung-Ying Kao
Cell & Bioscience|February 9, 2018
PML: Regulation and multifaceted function beyond tumor suppressionKuo-Sheng Hsu, Hung-Ying Kao
Cell & Bioscience|March 13, 2018
Correction to: PML: Regulation and multifaceted function beyond tumor suppressionKuo-Sheng Hsu, Hung-Ying Kao
The Journal of Biological Chemistry|July 18, 2013
β-Transducin repeat-containing protein 1 (β-TrCP1)-mediated silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) protein degradation promotes tumor necrosis factor α (TNFα)-induced inflammatory gene expressionKuo-Sheng Hsu, Hung-Ying Kao
The Journal of Biological Chemistry|November 21, 2014
α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding functionXuan Zhao, Kuo-Sheng Hsu, Jun Hee Lim, et al.
The Journal of Biological Chemistry|April 23, 2017
Dual regulation of Stat1 and Stat3 by the tumor suppressor protein PML contributes to interferon α-mediated inhibition of angiogenesisKuo-Sheng Hsu, Xuan Zhao, Xiwen Cheng, et al.
Science Advances|February 14, 2024
Uncovering receptor-ligand interactions using a high-avidity CRISPR activation screening platformLiping Yang, Timothy P Sheets, Yang Feng, et al.
Biorxiv : the Preprint Server for Biology|January 16, 2026
Engineering Functionality Optimized fully human B7-H3 CAR T Cells for Enhanced Solid Tumor TherapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
Cell Reports. Medicine|April 30, 2026
Engineering functionality-optimized fully human B7-H3 CAR T cells for enhanced solid tumor therapyPradip Bajgain, Yang Feng, Mariela Puebla, et al.
The Journal of Clinical Investigation|June 5, 2018
Tumor stroma-targeted antibody-drug conjugate triggers localized anticancer drug releaseChristopher Szot, Saurabh Saha, Xiaoyan M Zhang, et al.
Pageof 2